Clinical Trials Browser

Completed × Hemangiosarcoma × cemiplimab × Clear all

NCT04873375 2024-10-31

Cemiplimab for Secondary Angiosarcomas

Phase 2 Completed

Hemangiosarcoma, Neoplasm Metastasis, Sarcoma